Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
66582-26-1
69703-25-9
10316-00-4
136533-09-0
29984-16-5
1461705-22-5
2100306-53-2 | Bis-PEG4-t-butyl ester | AA019EB7 | MFCD28096679
2183473-27-8 | BDP TR azide | AA019EFS | MFCD31580115
2090618-38-3 | 5-bromo-2-methoxy-4-(trifluoromethyl)benzoic acid | AA019EJ4 | MFCD28348675
865798-15-8 | Ethyl 5-bromo-1-methyl-1h-imidazole-2-carboxylate | AA019EMA | MFCD18249878
1823776-36-8 | tert-Butyl 2-(4-methoxyphenyl)-4-oxopiperidine-1-carboxylate | AA019EPH | MFCD28119028
2096333-41-2 | (2-Fluoro-5-((4-nitrophenyl)carbamoyl)phenyl)boronic acid | AA019ESK | MFCD20265386
847239-89-8 | 4-bromo-N-(3,5-difluorophenyl)benzenesulfonamide | AA019EW6 | MFCD06635185
1182358-83-3 | 3-(Hydroxymethyl)-4-methyl-1H-1,2,4-triazol-5(4H)-one | AA019EZ6 | MFCD22393449
56995-20-1 | Flupirtine | AA019FSF | MFCD00864265
1005168-10-4 | PAC-14028 | AA019G91 | MFCD28502100